ERBB2 and breast carcinoma: ICAM1 expression is exclusive to triple-negative and HER2-positive breast cancer but is induced by proinflammatory cytokines such as TNF–α, IFN–γ, and IL–1β, independent of the tumor hormone receptor status, and is linked to high immune cell infiltration [60].